IPC
NVS icon

Independent Portfolio Consultants’s Novartis NVS Stock Holding History

Independent Portfolio Consultants’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.05M Sell
14,036
-2,274
-14% -$161K 0.44% 41
2017
Q1 		$1.08M Sell
16,310
-1,285
-7% -$85.6K 0.37% 67
2016
Q4 		$1.15M Buy
17,595
+835
+5% +$54.2K 0.38% 65
2016
Q3 		$1.19M Buy
16,760
+279
+2% +$20.3K 0.37% 68
2016
Q2 		$1.22M Sell
16,481
-631
-4% -$43.6K 0.38% 63
2016
Q1 		$1.11M Sell
17,112
-4,514
-21% -$307K 0.31% 99
2015
Q4 		$1.67M Sell
21,626
-13,771
-39% -$1.09M 0.49% 53
2015
Q3 		$2.92M Sell
35,397
-9,821
-22% -$874K 0.63% 29
2015
Q2 		$3.98M Sell
45,218
-8,900
-16% -$816K 0.8% 18
2015
Q1 		$4.78M Sell
54,118
-1,853
-3% -$164K 0.98% 8
2014
Q4 		$4.65M Buy
55,971
+32,313
+137% +$2.68M 0.94% 7
2014
Q3 		$2M Sell
23,658
-3,229
-12% -$261K 0.54% 32
2014
Q2 		$2.18M Sell
26,887
-686
-2% -$54K 0.61% 25
2014
Q1 		$2.1M Sell
27,573
-2,913
-10% -$212K 0.67% 17
2013
Q4 		$2.2M Buy
30,486
+2,773
+10% +$193K 0.77% 7
2013
Q3 		$1.91M Sell
27,713
-2,471
-8% -$163K 0.76% 2
2013
Q2 		$1.91M Buy
+30,184
New +$1.96M 0.86% 1

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Independent Portfolio Consultants's NVS Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Novartis (NVS) stake by 14% in Q2 2017, selling an estimated $161K and leaving 14,036 shares worth $1.05M. The position accounts for 0.44% of the portfolio, ranked #41.

Independent Portfolio Consultants first reported a position in NVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.78M in Q1 2015. 921 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

  • Independent Portfolio Consultants held 14,036 shares of Novartis worth $1.05M as of Q2 2017.
  • Independent Portfolio Consultants sold 2,274 Novartis shares in Q2 2017, an estimated $161K.
  • Novartis made up 0.44% of Independent Portfolio Consultants's portfolio in Q2 2017, its #41 holding.
  • Independent Portfolio Consultants first reported a position in Novartis in Q2 2013 and has held it in 17 quarters since.
  • Independent Portfolio Consultants's Novartis position peaked at $4.78M in Q1 2015.
  • 921 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.